Healthcare reform initiatives that had drifted for years amid doctor-government conflicts and political burdens have recently returned to the policy track all at once. The government views the simultaneous resumption of discussions on sensitive issues—including medical school enrollment adjustments, resident physician returns, telemedicine institutionalization, and strengthening regional essential healthcare—as a result of sufficient accumulated discussions across the medical community and society, with conditions for policy implementation now reaching maturity.
"Recent healthcare policies may appear to be moving quickly, but this is actually a natural transition resulting from accumulated political and social discussions and conflicts," a senior Ministry of Health and Welfare official said Wednesday. "For healthcare reform, process and legitimacy are more important than speed."
Regarding the return of medical students and resident physicians, the official assessed that "rather than the government doing something to bring them back, 18 months of accumulated conflict and fatigue led to a consensus within the medical community that 'it's time to return.'" The official emphasized that a voluntary return phase emerged after sufficient time, rather than reigniting doctor-government tensions.
A cautious approach continued regarding healthcare workforce policy. "The physician workforce issue is not something where numbers should be hastily decided—it requires expert-centered projections and social consensus," the official said. "Policies that fail to secure procedural legitimacy ultimately cannot be sustained." The official explained that current discussions on physician workforce projections are at a stage of reviewing various scenarios rather than predetermining specific conclusions.
Strengthening regional essential healthcare and redefining the role of national university hospitals were mentioned in the same context. Citing the concentration of cancer patients in the Seoul metropolitan area, the official said, "A structure where patients travel between Seoul and their regions for extended treatment periods is a significant burden for both patients and their families. Building a regionally complete healthcare system centered on national university hospitals is a task that can no longer be postponed."
On drug pricing policy, the official effectively signaled the possibility of intensive structural adjustments. "Since drug prices are paid through public insurance premiums, insurers cannot help but consider value for money," the official said. "A structure where excessive drug prices are maintained relative to effectiveness can no longer continue." While the official mentioned the need to consider industry investment conditions, the priorities of drug pricing policy were made clear: cost efficiency and fiscal soundness.
